Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Vancomycin-resistant Staphylococcus aureus
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==History== Three classes of vancomycin-resistant ''S. aureus'' have emerged that differ in vancomycin [[minimum inhibitory concentration|susceptibilities]]: vancomycin-intermediate ''S. aureus'' (VISA), heterogeneous vancomycin-intermediate ''S. aureus'' (hVISA), and high-level vancomycin-resistant ''S. aureus'' (VRSA).<ref name="pmid17888634">{{cite journal |author=Appelbaum PC |title=Reduced glycopeptide susceptibility in methicillin-resistant ''Staphylococcus aureus'' (MRSA) |journal=Int. J. Antimicrob. Agents |volume=30 |issue=5 |pages=398–408 |date=November 2007 |pmid=17888634 |doi=10.1016/j.ijantimicag.2007.07.011 }}</ref> ===Vancomycin-intermediate ''S. aureus'' (VISA)=== Vancomycin-intermediate ''S. aureus'' (VISA) ({{IPAc-en|ˈ|v|iː|s|ə}} or {{IPAc-en|v|iː|aɪ|ɛ|s|eɪ}}) was first identified in [[Japan]] in 1996<ref>{{cite journal|last1=Hiramatsu|first1=K.|last2=Hanaki|first2=H.|last3=Ino|first3=T.|last4=Yabuta|first4=K.|last5=Oguri|first5=T.|last6=Tenover|first6=F. C.|date=1997-07-01|title=Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.|journal=Journal of Antimicrobial Chemotherapy|language=en|volume=40|issue=1|pages=135–136|doi=10.1093/jac/40.1.135|issn=0305-7453|pmid=9249217|doi-access=free}}</ref> and has since been found in hospitals elsewhere in [[Asia]], as well as in [[the United Kingdom]], [[France]], the [[United States|U.S.]], and [[Brazil]]. It is also termed GISA (glycopeptide-intermediate ''Staphylococcus aureus''), indicating resistance to all glycopeptide antibiotics. These bacterial strains present a thickening of the cell wall, which is believed to reduce the ability of vancomycin to diffuse into the division septum of the cell required for effective vancomycin treatment.<ref>{{cite journal |vauthors=Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML |title=Reduced vancomycin susceptibility in ''Staphylococcus aureus'', including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications |journal=Clin. Microbiol. Rev. |date=Jan 2010 | volume=23 |issue=1 |pages=99–139 |doi=10.1128/CMR.00042-09 |pmid=20065327 |pmc=2806658 |url=}}</ref> [[File:S aureus blood agar.jpg|thumb|''[[Staphylococcus aureus|S. aureus]]'' [[blood agar]]]] ===Vancomycin-resistant ''S. aureus'' (VRSA)=== High-level vancomycin resistance in ''S. aureus'' has rarely been reported.<ref name="pmid21109164">{{cite journal |author=Gould IM |title=VRSA-doomsday superbug or damp squib? |journal=Lancet Infect Dis |volume=10 |issue=12 |pages=816–8 |date=December 2010 |pmid=21109164 |doi=10.1016/S1473-3099(10)70259-0 }}</ref> ''[[In vitro]]'' and ''[[in vivo]]'' experiments reported in 1992 demonstrated that vancomycin resistance genes from ''[[Enterococcus faecalis]]'' could be transferred by [[horizontal gene transfer|gene transfer]] to ''S. aureus'', conferring high-level vancomycin resistance to ''S. aureus''.<ref>{{Cite book|title = Bacterial Toxins: Genetics, Cellular Biology and Practical Applications|url = https://books.google.com/books?id=FdAAAgAAQBAJ&q=vancomycin%2520resistance%2520genes%2520from%2520Enterococcus%2520faecalis%2520could%2520be%2520transferred%2520by%2520horizontal%2520gene%2520transfer%2520to%2520S.%2520aureus%252C%2520conferring%2520high-level%2520vancomycin%2520resistance%2520to%2520S.%2520aureus&pg=PA119|publisher = Horizon Scientific Press|date = 2013|isbn = 9781908230287|first = Thomas|last = Proft}}</ref> Until 2002 such a genetic transfer was not reported for wild ''S. aureus'' strains. In 2002, a VRSA strain ({{IPAc-en|ˈ|v|ɜr|s|ə}} or {{IPAc-en|v|iː|ɑr|ɛ|s|eɪ}}) was isolated from a patient in Michigan.<ref>{{Cite book|title = Antimicrobial Resistance in Bacteria|url = https://books.google.com/books?id=sQ7URquB4YcC&q=Vancomycin-resistant%2520S.%2520aureus%2520%2520%2520horizontal%2520gene%2520transfer&pg=PT45|publisher = Horizon Scientific Press|date = 2007|isbn = 9781904933243|first = Carlos F.|last = Amábile-Cuevas}}</ref> The isolate contained the ''mecA'' gene for [[methicillin-resistant Staphylococcus aureus|methicillin resistance]]. Vancomycin [[minimum inhibitory concentration|MICs]] of the VRSA isolate were consistent with the VanA phenotype of ''[[Enterococcus]]'' species, and the presence of the ''vanA'' gene was confirmed by [[polymerase chain reaction]]. The DNA sequence of the VRSA ''vanA'' gene was identical to that of a [[vancomycin-resistant Enterococcus|vancomycin-resistant strain of ''Enterococcus faecalis'']] recovered from the same catheter tip. The ''vanA'' gene was later found to be encoded within a [[transposon]] located on a [[plasmid]] carried by the VRSA isolate. This transposon, Tn''1546'', confers ''vanA''-type vancomycin resistance in enterococci.<ref name="pmid16323116">{{cite journal |author=Courvalin P |title=Vancomycin resistance in gram-positive cocci |journal=Clin. Infect. Dis. |volume=42 |pages=S25–34 |date=January 2006 |issue=Suppl 1 |pmid=16323116 |doi=10.1086/491711 |doi-access=free }}</ref> As of 2019, 52 VRSA strains have been identified in the United States, India, Iran, Pakistan, Brazil, and Portugal.<ref>{{cite journal |last1=Cong |first1=Yanguang |last2=Yang |first2=Sijin |last3=Rao |first3=Xiancai |title=Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features |journal=J Adv Res |date=2020 |volume=21 |pages=169–176 |doi=10.1016/j.jare.2019.10.005 |pmid=32071785|pmc=7015472 }}</ref> ===Heterogeneous vancomycin-intermediate S. aureus (hVISA)=== The definition of hVISA according to Hiramatsu et al. is a strain of Staphylococcus aureus that gives resistance to vancomycin at a frequency of 10<sup>−6</sup> colonies or even higher.<ref>{{Cite book|title = Emerging Infections in Asia|url = https://books.google.com/books?id=5WKoOibILtkC&q=heterogeneous%2520vancomycin-intermediate%2520S.%2520aureus&pg=PA234|publisher = Springer Science & Business Media|date = 2008-04-11|isbn = 9780387757216|first1 = Yichen|last1 = Lu|first2 = Max|last2 = Essex|first3 = Bryan|last3 = Roberts}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)